. 2020 Jun 4;10(4):721–734. doi: 10.1007/s13555-020-00401-y

Table 1.

Incidence and prevalence of HS, PsO, and HS-PsO cohorts

Group	Prevalence^a	Incidence^b
	Cases per 100,000	Cases per 100,000
HS	68.1	10.1
PsO	1962.9	96.6
HS-PsO	4.3	0.2

^aPopulation includes patients with a diagnosis of HS, PsO, or both between January 1, 2012 and December 31, 2016; ^bPopulation includes patients with a new diagnosis of HS, PsO, or both between January 1, 2017 and December 31, 2017; HS, hidradenitis suppurativa; PsO, psoriasis; HS-PsO, hidradenitis suppurativa with concurrent psoriasis